{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T12:49:22Z","timestamp":1776948562812,"version":"3.51.4"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1097\/adm.0000000000000024","type":"journal-article","created":{"date-parts":[[2014,2,21]],"date-time":"2014-02-21T10:28:31Z","timestamp":1392978511000},"page":"84-89","source":"Crossref","is-referenced-by-count":17,"title":["Observational Study on Medications Prescribed to Dual-Diagnosis Outpatients"],"prefix":"10.1097","volume":"8","author":[{"given":"Lara","family":"Grau-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Roncero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constanza","family":"Daigre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laia","family":"Miquel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Barral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bego\u00f1a","family":"Gonzalvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Collazos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miquel","family":"Casas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"1","key":"R1-2-20210126","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/hup.1077","article-title":"The association between concurrent psychotropic medications and self-reported adherence with taking a mood stabilizer in bipolar disorder.","volume":"25","author":"Bauer","year":"2010","journal-title":"Hum Psychopharmacol"},{"issue":"8","key":"R2-2-20210126","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1176\/appi.ps.54.8.1086","article-title":"Antipsychotic polypharmacy in the ambulatory care setting. 1993-2000.","volume":"54","author":"Botts","year":"2003","journal-title":"Psychiatr Serv"},{"key":"R3-2-20210126","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1176\/ajp.142.9.1106","article-title":"Effect of methadone plus neuroleptics on treatment resistant chronic paranoid schizophrenia.","volume":"142","author":"Brizer","year":"1985","journal-title":"Am J Psychiatry"},{"issue":"6","key":"R4-2-20210126","first-page":"350","article-title":"Spanish Working Group on bipolar disorders in dual diagnosis. Bipolar disorder associated to substance use disorders (dual diagnosis). Systematic review of the scientific evidence and expert consensus.","volume":"36","author":"Casas","year":"2008","journal-title":"Actas Esp Psiquiatr"},{"issue":"1","key":"R5-2-20210126","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/oxfordjournals.schbul.a006928","article-title":"Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy.","volume":"28","author":"Clark","year":"2002","journal-title":"Schizophr Bull"},{"issue":"8","key":"R6-2-20210126","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance.","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"},{"issue":"2","key":"R7-2-20210126","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2648.2008.04879.x","article-title":"Psychosocial treatments for people with co-occurring severe mental illness and substance misuse: systematic review.","volume":"65","author":"Cleary","year":"2009","journal-title":"J Adv Nurs"},{"key":"R10-2-20210126","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2125.2007.03029.x","article-title":"Identifying how age and gender influence prescription drug use in a primary health care environment in Catalonia, Spain.","volume":"65","author":"Fernandez-Liz","year":"2008","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"R13-2-20210126","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1034\/j.1600-0447.2002.01331.x","article-title":"Antipsychotic combination therapy in schizophrenia: a review of efficacy and risks of current combinations.","volume":"106","author":"Freudenreich","year":"2002","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"R14-2-20210126","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4088\/JCP.v61n0104","article-title":"The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study.","volume":"61","author":"Frye","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R15-2-20210126","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.4088\/JCP.v65n1013","article-title":"Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.","volume":"65","author":"Ganguly","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"R16-2-20210126","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jad.2008.11.016","article-title":"Polypharmacy prevalence rates in the treatment of unipolar depression in an outpatient clinic.","volume":"117","author":"Glezer","year":"2009","journal-title":"J Affect Disord"},{"issue":"2","key":"R17-2-20210126","first-page":"115","article-title":"Risk factors of relapse in drug dependent patients after hospital detoxification.","volume":"24","author":"Grau-Lopez","year":"2012","journal-title":"Adicciones"},{"issue":"2","key":"R18-2-20210126","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/08897077.2011.634968","article-title":"Psychosis induced by the interaction between disulfiram and methylphenidate may be dose dependent.","volume":"33","author":"Grau-Lopez","year":"2012","journal-title":"Substance Abuse"},{"issue":"4","key":"R19-2-20210126","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0740-5472(02)00278-7","article-title":"Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program.","volume":"23","author":"Green","year":"2002","journal-title":"J Subst Abuse Treat"},{"key":"R20-2-20210126","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/09595230601037000","article-title":"Dual diagnosis in Spain.","volume":"26","author":"Gual","year":"2007","journal-title":"Drug Alcohol Rev"},{"key":"R21-2-20210126","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1176\/appi.ajp.161.1.139","article-title":"Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery.","volume":"161","author":"Havassy","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R22-2-20210126","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/cbm.669","article-title":"Pharmacological issues in the management of people with mental illness and problems with alcohol and illicit drug misuse.","volume":"17","author":"Hilton","year":"2007","journal-title":"Crim Behav Ment Health"},{"issue":"2","key":"R23-2-20210126","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.ALC.0000113409.47937.6C","article-title":"Development of novel pharmacotherapies for the treatment of alcohol dependence: focus on antiepileptics.","volume":"28","author":"Johnson","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"R24-2-20210126","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.addbeh.2011.09.010","article-title":"Treatment of substance abusing patients with comorbid psychiatric disorders.","volume":"37","author":"Kelly","year":"2012","journal-title":"Addict Behav"},{"key":"R25-2-20210126","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0740-5472(88)90042-6","article-title":"Differential diagnosis of psychiatric comorbidity in substance abusers.","volume":"5","author":"Kosten","year":"1988","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"R26-2-20210126","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1176\/ps.2007.58.4.489","article-title":"Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns.","volume":"58","author":"Kreyenbuhl","year":"2007","journal-title":"Psychiatr Serv"},{"key":"R27-2-20210126","first-page":"1019","article-title":"Assessment and classification of patients with psychiatric and substance abuse syndromes.","volume":"40","author":"Lehman","year":"1989","journal-title":"Hosp Community Psychiatry"},{"issue":"6","key":"R28-2-20210126","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/WNF.0b013e31815cba78","article-title":"Antipsychotic polypharmacy in patients with schizophrenia in a brief hospitalization unit.","volume":"31","author":"Lerma-Carrillo","year":"2008","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"R29-2-20210126","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/08897077.2012.709223","article-title":"Gender differences in dually-diagnosed outpatients.","volume":"34","author":"Miquel","year":"2013","journal-title":"Subst Abuse"},{"issue":"1","key":"R30-2-20210126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archgenpsychiatry.2009.175","article-title":"National trends in psychotropic medication polypharmacy in office-based psychiatry.","volume":"67","author":"Mojtabai","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"R31-2-20210126","first-page":"80","article-title":"Psychosis during disulfiram therapy for alcoholism.","volume":"95","author":"Murthy","year":"1997","journal-title":"J Indian Med Assoc"},{"issue":"3","key":"R32-2-20210126","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/YCO.0b013e328351a3e0","article-title":"Treatment of dual diagnosis disorders.","volume":"25","author":"Murthy","year":"2012","journal-title":"Curr Opin Psychiatry"},{"issue":"6","key":"R33-2-20210126","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/01.pra.0000341890.05383.45","article-title":"Polypharmacy with second-generation antipsychotics: a review of evidence.","volume":"14","author":"Pandurangi","year":"2008","journal-title":"Psychiatr Pract"},{"issue":"2","key":"R34-2-20210126","first-page":"97","article-title":"Polypharmacy: when is it rational J Psychiatr P","volume":"13","author":"Preskorn","year":"2007","journal-title":"ract"},{"key":"R35-2-20210126","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug use: results from the Epidemiologic Catchment Area (ECA).","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"key":"R36-2-20210126","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/archpsyc.1984.01790210016003","article-title":"The NIMH Epidemiologic Catchment Area program: historical context, major objectives, and study population characteristics.","volume":"41","author":"Regier","year":"1984","journal-title":"Arch Gen Psychiatry"},{"key":"R37-2-20210126","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5414\/CPP43411","article-title":"Appropriateness of benzodiazepine prescribing in general practice.","volume":"43","author":"Rijswijk","year":"2005","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"4","key":"R38-2-20210126","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.jcp.0000169624.37819.60","article-title":"Quetiapine improves sleep disturbances in combat veterans with PTSD: sleep data from a prospective, open-label study.","volume":"25","author":"Robert","year":"2005","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"R39-2-20210126","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/ADT.0b013e318227ecdc","article-title":"Protocols of dual diagnosis intervention in schizophrenia.","volume":"10","author":"Roncero","year":"2011","journal-title":"Addict Disord Their Treat"},{"key":"R40-2-20210126","first-page":"5","article-title":"Therapeutic management and comorbidities in opiate-dependent patients undergoing a replacement therapy programme in Spain: the PROTEUS study.","volume":"13","author":"Roncero","year":"2011","journal-title":"Heroin Addict Relat Clin Probl"},{"issue":"2","key":"R41-2-20210126","first-page":"57","article-title":"Reduction of psychotic symptoms during the use of exogenous opiates.","volume":"14","author":"Ros-Cucurull","year":"2012","journal-title":"Heroin Addict Relat Clin Probl"},{"issue":"2","key":"R42-2-20210126","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0213-9111(02)71643-9","article-title":"Prevalence of drug utilization in the adult population of Catalonia, Spain.","volume":"16","author":"Sans","year":"2002","journal-title":"Gac Sanit"},{"issue":"9","key":"R43-2-20210126","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1741-7015-9-119","article-title":"Novel pharmacotherapeutic treatments for cocaine addiction.","volume":"3","author":"Shorter","year":"2011","journal-title":"BMC Med"},{"issue":"3","key":"R44-2-20210126","first-page":"249","article-title":"Pilot study on the prevalence of dual pathology in community mental health and substance misuse services in Madrid.","volume":"23","author":"Szerman","year":"2011","journal-title":"Adicciones"},{"issue":"1","key":"R45-2-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ADT.0b013e31826e7b6a","article-title":"Rethinking dual disorderspathology.","volume":"12","author":"Szerman","year":"2013","journal-title":"Addict Disord Their Treat"},{"issue":"14","key":"R46-2-20210126","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1080\/10826080802290240","article-title":"Quetiapine in the treatment of sleep disturbances associated with addictive conditions: a retrospective study.","volume":"43","author":"Teran","year":"2008","journal-title":"Subst Use Misuse"},{"issue":"1","key":"R47-2-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.09.004","article-title":"Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis.","volume":"78","author":"Torrens","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"R48-2-20210126","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.schres.2011.05.013","article-title":"The evolution of antipsychotic switch and polypharmacy in natural practicea longitudinal perspective.","volume":"130","author":"Tsutsumi","year":"2011","journal-title":"Schizophr Res"},{"issue":"1","key":"R49-2-20210126","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00131746-200101000-00003","article-title":"The use of medication for relapse prevention in substance dependence disorders.","volume":"7","author":"Welsh","year":"2001","journal-title":"J Psychiatr Pract"}],"container-title":["Journal of Addiction Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ADM.0000000000000024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T06:21:46Z","timestamp":1648362106000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01271255-201403000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/adm.0000000000000024","relation":{},"ISSN":["1932-0620"],"issn-type":[{"value":"1932-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}